Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
Die Kommerzialisierung der räumlichen Intelligenz in Billionen-Märkten beginnt jetzt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
258 Leser
Artikel bewerten:
(1)

Bedfont Scientific Ltd. teams up with GI Cognition to launch Hydrogen and Methane Breath Testing 'Home Kits' to help improve Gastric Health remotely

Bedfont presents its new Hydrogen and Methane Breath Testing Home Kits in association with GI Cognition

MAIDSTONE, England, June 1, 2021 /PRNewswire/ -- With the pandemic of COVID-19 bringing a halt to most medical tests and procedures, it has highlighted a need to safely, easily, and remotely find a way for health services to continue treating their patients, especially in the field of Gastroenterology. Global breath analysis manufacturer, Bedfont Scientific Ltd., has teamed up with GI Cognition to do just that in launching its new Hydrogen and Methane Breath Testing (HMBT) 'Home Kits' to help improve Gastric Health remotely.

Known for their innovative medical devices, Bedfont brings their 32 years of Hydrogen and Methane monitoring knowledge and has created a simple and patient-friendly HBMT Home Kit, which allows patients to be tested remotely for many digestive issues, including food intolerances, IBS, and SIBO. The Home Kits will be distributed by GI Cognition; a UK network of qualified GI physiologists, providing a unique and innovative mobile gastrointestinal physiology service.

According to NICE, IBS prevalence in the UK population is estimated to be between 10% and 20%1 and SIBO affects 1 in 7 according to the London Gastroenterology Centre2. GI Cognition was first established to ease the pressure on UK hospitals who deal with long waiting times and convoluted processes for their gastroenterology outpatients. By teaming up with Bedfont to offer HBMT Home Kits, they can not only accomplish this, but also help Bedfont to raise awareness of gastrointestinal health and give the patient more knowledge and control of their own gastric health.

Dr. Jafar Jafari, Head Of Upper GI Physiology Service at Guys and St Thomas Hospital, and Executive Director at GI Cognition, explains, "Hydrogen and methane breath testing is an invaluable tool in helping to detect gastrointestinal disorders, but unfortunately there are not enough qualified GI physiologists in the UK to meet the growing demand from patients and hospitals, causing a shortage of upper GI testing services, including HBMT; GI cognition was established to remedy this. We are excited to be working with Bedfont on HBMT Home Kits to help bridge the gap."

Jason Smith, Managing Director at Bedfont, adds, "For some time there has been a need to help reduce the pressure on gastroenterology health services and with the pandemic, we decided to focus on developing the Home Kits sooner. Through remote breath analysis, more patients can be seen, without having to leave the comfort of their homes, meaning they can receive great care and stop living in discomfort by better understanding and taking control of their digestive health."

References:

  1. Introduction | Irritable bowel syndrome in adults: diagnosis and management | Guidance | NICE [Internet]. Nice.org.uk. 2021 [cited 20 May 2008]. Available from: https://www.nice.org.uk/guidance/cg61/chapter/introduction#:~:text=IBS%20most%20often%20affects%20people,of%20IBS%20in%20older%20people.
  2. SIBO (Small Intestinal Bacterial Overgrowth) - Treating, Testing & Preventing [Internet]. London Gastroenterology Centre. 2018 [cited 20 May 2021]. Available from: https://www.gastrolondon.co.uk/overview-of-diagnosis-and-management-of-small-intestinal-bacterial-overgrowth/

About Bedfont

Established in 1976, Bedfont Scientific Limited is a second generation family company that has specialised in the design and manufacture of exhaled breath and gas monitoring instruments for medical application, globally, for over 40 years. Bedfont is revered as a pioneer in the breath analysis market with their products now available in over 76 countries across the world thanks to their unprecedented network of appointed distributors. Their aim is to continue innovating and improving health worldwide.

Products include:

  • Smokerlyzer:
    Range of carbon monoxide monitors for use in smoking cessation programmes
  • NObreath :
    Fractional exhaled Nitric Oxide (FeNO) device to provide accurate analysis of airway inflammation
  • Gastrolyzer :
    Range of breath hydrogen and methane monitors to aid in the detection of gastrointestinal disorder.
  • ToxCO :
    Carbon monoxide monitor used by the emergency services to detect carbon monoxide poisoning
  • Medi-Gas Check:
    Range of fixed and portable gas detection monitors, used to verify and validate the quantity and quality of medical gas administered to patients

www.bedfont.com

© 2021 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.